CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL von Nassiri, Farshad, Patil, Vikas, Yefet, Leeor, Singh, Olivia, Liu, Jeff, Dang, Rachel, Yamaguchi, Takafumi, Daras, Mariza, Cloughesy, Timothy, Colman, Howard, Kumthekar, Priya, Chen, Clark, Aiken, Robert, Groves, Morris, Ong, Shirley, Ramakrishna, Rohan, Vogelbaum, Michael A, Khagi, Simon, Kaley, Thomas, Melear, Jason, Peereboom, David, Rodriguez, Analiz, Yankelevich, Maxim, Nair, Suresh, Puduvalli, Vinay, Aldape, Kenneth, Gao, Andrew, Lopez-Janeiro, Alvaro, de Andrea, Carlos, Alonso, Marta, Boutros, Paul, Robbins, Joan, Mason, Warren, Sonaben, Adam, Stupp, Roger, Fueyo-Margareto, Juan, Gomez-Manzano, Candelaria, Lang, Frederick, Zadeh, Gelareh

Volltext